David Scadden - Jun 13, 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Director
Signature
/s/ William Cook, as Attorney-in-fact for David Scadden
Stock symbol
AGIO
Transactions as of
Jun 13, 2023
Transactions value $
$0
Form type
4
Date filed
6/15/2023, 04:28 PM
Previous filing
Jun 5, 2023
Next filing
Jun 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock units Award $0 +3.39K $0.00 3.39K Jun 13, 2023 Common stock 3.39K Direct F1, F2
transaction AGIO Stock options (right to buy) Award $0 +19K $0.00 19K Jun 13, 2023 Common stock 19K $26.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2 The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
F3 This option was granted on June 13, 2023. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2024.